bromocriptine has been researched along with Fibrous Dysplasia, Polyostotic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alaghband-Zadeh, J; Chung, KF; Guz, A | 1 |
Chanson, P; Derome, PJ; Dib, A; Visot, A | 1 |
Cavanah, SF; Dons, RF | 1 |
Chiarini, V; Cremonini, N; Graziano, E; Sforza, A; Zampa, GA | 1 |
Ladenson, PW; Sherman, SI | 1 |
Abs, R; Beckers, A; De Schepper, A; Hennen, G; Stevenaert, A; Van de Vyver, FL | 1 |
Hirooka, M; Itoh, M; Nagasaka, A; Nakagawa, H; Nakagawa, K; Nakai, A; Nihei, N; Ohyama, T; Sugiura, T; Yabe, Y | 1 |
1 review(s) available for bromocriptine and Fibrous Dysplasia, Polyostotic
Article | Year |
---|---|
McCune-Albright syndrome: how many endocrinopathies can one patient have?
Topics: Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Heart Failure; Humans; Hyperparathyroidism; Hyperprolactinemia; Hyperthyroidism; Iodine Radioisotopes; Middle Aged; Puberty, Precocious; Radiography | 1993 |
6 other study(ies) available for bromocriptine and Fibrous Dysplasia, Polyostotic
Article | Year |
---|---|
Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
Topics: Acromegaly; Bromocriptine; Child; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypopituitarism; Hypothalamus; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1983 |
McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1994 |
Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Hyperprolactinemia; Octreotide; Pituitary Neoplasms | 1992 |
Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.
Topics: Bromocriptine; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Function Tests | 1992 |
Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.
Topics: Acromegaly; Adenoma; Adult; Brain; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Goiter; Growth Hormone; Humans; Magnetic Resonance Imaging; Menstruation Disturbances; Octreotide; Pituitary Neoplasms; Prolactin | 1990 |
Gigantism associated with McCune-Albright's syndrome.
Topics: Adolescent; Bromocriptine; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Gigantism; Growth Hormone; Humans; Levodopa; Male; Radiography; Radionuclide Imaging; Thyrotropin-Releasing Hormone | 1985 |